POPLAR

NCT01903993 📎

Regimen

Experimental: atezolizumab
Control: docetaxel

Population

Pretreated advanced NSCLC

Key finding

mOS 12.6 vs 9.7 mo, HR 0.73 (0.53-0.99); dose-response with PD-L1

Source: PMID 26970723

Timeline

Enrollment start: 2013-08-06 📎

Guideline citations

NCCN NSCLC Version 5.2026 (p.248)